Advertisement

Topics

PEP-Therapy, Institut Curie and Gustave Roussy Obtain 2,9 M€ to Develop a Novel Peptide in Oncology

09:00 EDT 17 Apr 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
The partners join together to develop this new therapeutic approach up to clinical proof of concept PEP-Therapy, Institut Curie and Gustave Roussy join together to conduct the Clever-Peptide project.It aims at the dev...

Other Sources for this Article

PEP-Therapy:
Antoine Prestat, +33 1 44 27 89 88
CEO
hello.pep@pep-therapy.com
or
Institut Curie:
Catherine Goupillon, +33 1 56 24 55 23
Press Relations manager
service.presse@curie.fr
or
Gustave Roussy:
Claire Parisel, +33 1 42 11 50 59 – +33 6 17 66 00 26
Media Relations
claire.parisel@gustaveroussy.fr

NEXT ARTICLE

More From BioPortfolio on "PEP-Therapy, Institut Curie and Gustave Roussy Obtain 2,9 M€ to Develop a Novel Peptide in Oncology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...